Amgen (AMGN) Swing
- Solid company
- Has had downward trend for weeks but is now at support
- For the six months ended 30 June 2021, Amgen, Inc. revenues increased less than 1% to 12.43B.
- Net income decreased 42% to 2.11B. Revenues reflect Prolia segment increase of 20% to 1.57B
- Other revenues segment increase of 28% to 721M, also reflect Enbrel segment decrease of14% to 2.07B, Neulasta segment decrease of 19% to 968M.
- Net income was partially offset by Research and development increase of 7% to 2.05B (expense), Selling.
- Has had downward trend for weeks but is now at support
- For the six months ended 30 June 2021, Amgen, Inc. revenues increased less than 1% to 12.43B.
- Net income decreased 42% to 2.11B. Revenues reflect Prolia segment increase of 20% to 1.57B
- Other revenues segment increase of 28% to 721M, also reflect Enbrel segment decrease of14% to 2.07B, Neulasta segment decrease of 19% to 968M.
- Net income was partially offset by Research and development increase of 7% to 2.05B (expense), Selling.
إخلاء المسؤولية
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.